Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer

12 Aug 2016

Abstract excerpt

// Mei-Ren Pan 1, 2 , Ming-Chuan Hsu 3 , Chi-Wen Luo 4 , Li-Tzong Chen 3, 5 , Yan-Shen Shan 6, 7 , Wen-Chun Hung 3, 8 1 Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan 2 Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan 3 National Institute of Cancer Research, National Health Research Institutes, Tainan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27531902
DOI: 10.18632/oncotarget.11256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancerPMID 27531902Read ↗

Advances in pancreatic cancer epigenetics: From the mechanism to the clinicSemantic proximity Read ↗

Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.Semantic proximity Read ↗

Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects.Semantic proximity Read ↗

Epigenetic targeting in pancreatic cancerSemantic proximity Read ↗

Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer CellsSemantic proximity Read ↗

Emerging role of microRNAs to tackle drug resistance in pancreatic cancerSemantic proximity Read ↗

The role of histone methylation in the development of digestive cancers: a potential direction for cancer managementSemantic proximity Read ↗

Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cellsSemantic proximity Read ↗

Multidrug resistance genes screening of pancreatic cancer based on sensitivity profile to chemotherapeutic drugsSemantic proximity Read ↗

MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potentialSemantic proximity Read ↗

DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implicationsSemantic proximity Read ↗

Noncoding RNAs in drug-resistant pancreatic cancer: A reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.